A predictive factor of the quality of microarray comparative genomic hybridization analysis for formalin-fixed paraffin-embedded archival tissue

Diagnostic Molecular Pathology

Volumn 22, Issue 3, 2013, Pages 174-180

  Nakao, Kenjiro ^a   Oikawa, Masahiro ^a,b   Arai, Junichi ^a   Mussazhanova, Zhanna ^c   Kondo, Hisayoshi ^d   Shichijo, Kazuko ^c   Nakashima, Masahiro ^c   Hayashi, Tomayoshi ^a   Yoshiura, Koh Ichiro ^e   Hatachi, Toshiko ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Departments of Tumor and Diagnostic Pathology   (Japan)

^c Division of Scientific Data Registry   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

cancer; comparative genomic hybridization; cytogenetics; Formalin fixed paraffin embedded; microarray

Indexed keywords

DOUBLE STRANDED DNA; FORMALDEHYDE; PARAFFIN;

ARTICLE; BREAST CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA EXTRACTION; EMBEDDING; FROZEN SECTION; GENE AMPLIFICATION; LUNG CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; THYROID TUMOR; TISSUE MICROARRAY;

EID: 84883457082     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e31828191de     Document Type: Article

References (42)

1. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2004;11: 220-228.
2. Barrett MT, Scheffer A, Ben-Dor A, et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA. 2004;101:17765-17770. (Pubitemid 40051961)
3. Naylor TL, Greshock J, Wang Y, et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 2005;7:R1186-R1198.
4. Reis-Filho JS, Simpson PT, Gale T, et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract. 2005;201:713-725. (Pubitemid 41671175)
5. Fridlyand J, Snijders AM, Ylstra B, et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006; 6:96.
6. Climent J, Garcia JL, Mao JH, et al. Characterization of breast cancer by array comparative genomic hybridization. Biochem Cell Biol. 2007;85:497-508. (Pubitemid 47518044)
7. Loo LW, Ton C, Wang YW, et al. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer. 2008;47:1049-1066.
8. Melchor L, Honrado E, Garcia MJ, et al. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene. 2008; 27:3165-3175. (Pubitemid 351693170)
9. Andre F, Job B, Dessen P, et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res. 2009;15:441-451.
10. Hu X, Stern HM, Ge L, et al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res. 2009;7:511-522.
11. Johnson NA, Hamoudi RA, Ichimura K, et al. Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells. Lab Invest. 2006;86:968-978. (Pubitemid 44268171)
12. Gnanapragasam VJ. Unlocking the molecular archive: the emerging use of formalin-fixed paraffin-embedded tissue for biomarker research in urological cancer. BJU Int. 2010;105:274-278.
13. Nessling M, Richter K, Schwaenen C, et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res. 2005;65:439-447.
14. Thompson ER, Herbert SC, Forrest SM, et al. Whole genome SNP arrays using DNA derived from formalin-fixed, paraffin-embedded ovarian tumor tissue. Hum Mutat. 2005;26:384-389. (Pubitemid 41361806)
15. Paik S, Kim CY, Song YK, et al. Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol. 2005;2:246-254. (Pubitemid 40812455)
16. Paris PL, Sridharan S, Scheffer A, et al. High resolution oligonucleotide CGH using DNA from archived prostate tissue. Prostate. 2007;67:1447-1455. (Pubitemid 47435791)
17. Tuefferd M, De Bondt A, Van Den Wyngaert I, et al. Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays. Genes Chromosomes Cancer. 2008;47:957-964.
18. Oosting J, Lips EH, van Eijk R, et al. High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays. Genome Res. 2007;17:368-376. (Pubitemid 46376746)
19. Gunn S, Yeh IT, Lytvak I, et al. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. BMC Cancer. 2010;10:396.
20. Krijgsman O, Israeli D, Haan JC, et al. CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material. Genes Chromosomes Cancer. 2012;51:344-352.
21. Devries S, Nyante S, Korkola J, et al. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn. 2005;7:65-71. (Pubitemid 40310167)
22. Lyons-Weiler M, Hagenkord J, Sciulli C, et al. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues. Diagn Mol Pathol. 2008;17:3-13.
23. Hostetter G, Kim SY, Savage S, et al. Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples. Nucleic Acids Res. 2010;38:e9.
24. Wang Y, Carlton VE, Karlin-Neumann G, et al. High quality copy number and genotype data from FFPE samples using molecular inversion probe (MIP) microarrays. BMC Med Genomics. 2009;2:8.
25. Raap AK, van der Burg MJ, Knijnenburg J, et al. Array comparative genomic hybridization with cyanin cis-platinumlabeled DNAs. Biotechniques. 2004;37:130-134. (Pubitemid 38902671)
26. Joosse SA, van Beers EH, Nederlof PM. Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material. BMC Cancer. 2007;7:43.
27. Knijnenburg J, van der Burg M, Tanke HJ, et al. Optimized amplification and fluorescent labeling of small cell samples for genomic array-CGH. Cytometry A. 2007;71:585-591. (Pubitemid 47221720)
28. van Beers EH, Joosse SA, Ligtenberg MJ, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94:333-337. (Pubitemid 43151556)
29. Jacobs S, Thompson ER, Nannya Y, et al. Genome-wide, highresolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Res. 2007;67:2544-2551. (Pubitemid 46548939)
30. Oikawa M, Yoshiura K, Kondo H, et al. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization. Radiat Oncol. 2011;6:168.
31. Arai J, Tsuchiya T, Oikawa M, et al. Clinical and molecular analysis of synchronous double lung cancers. Lung cancer. 2012;77:281-287.
32. Oikawa M, Nagayasu T, Yano H, et al. Intracystic papillary carcinoma of breast harbors significant genomic alteration compared with intracystic papilloma: genome-wide copy number and LOH analysis using high-density single-nucleotide polymorphism microarrays. Breast J. 2011;17:427-430.
33. Little SE, Vuononvirta R, Reis-Filho JS, et al. Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics. 2006;87:298-306. (Pubitemid 43117451)
34. Pleasance ED, Stephens PJ, OMeara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010;463:184-190.
35. Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2010;463:191-196.
36. Shah SP, Morin RD, Khattra J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461:809-813.
37. Juul N, Szallasi Z, Eklund AC, et al. Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol. 2010;11:358-365.
38. Ding L, Ellis MJ, Li S, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010;464:999-1005.
39. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467: 1114-1117.
40. Campbell PJ, Stephens PJ, Pleasance ED, et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet. 2008;40:722-729. (Pubitemid 351748860)
41. Stephens PJ, McBride DJ, Lin ML, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009;462:1005-1010.
42. Corless CL. Medicine. Personalized cancer diagnostics. Science. 2011;334:1217-1218.